Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Immunomodulation by Transplanted Human Embryonic Stem Cell- Derived Oligodendroglial Progenitors in Experimental Autoimmune Encephalomyelitis.
Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
Inflammatory demyelinating diseases in children: an update.
Fingolimod Reduces Direct Medical Costs Compared to Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis in the Netherlands.
Clarification on neuromuscular conditions in careers article.
Negotiating the radiologically isolated syndrome.
Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.
White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
Regional anesthesia in patients with pre-existing neurologic disease.
Chemokines and chemokine receptors in multiple sclerosis.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod).
Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
Brain atrophy at onset and physical disability in multiple sclerosis.
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
Pages
« first
‹ previous
…
293
294
295
296
297
298
299
300
301
…
next ›
last »